Oramed (ORMP)
$2.09
0.005 (0.24%)
ORMP Stock Quote Delayed 30 Minutes
ORMP Stock Earnings: Oramed Pharmaceuticals Beats EPS for Q2 2024
ORMP stock results show that Oramed Pharmaceuticals beat analyst estimates for earnings per share the second quarter of 2024.
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Unlock Louis Navellier's
? Stock Report – FREE:
Is ? a BUY?
Powered by Portfolio Grader
A
B
C
D
F
?
Unlock Louis Navellier's
? Stock Report to Find Out – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Investing legend Louis Navellier rates ? a "?." Unlock his ? Stock Analysis to find out why – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Fundamental Grade
Quantitative Grade
- Sales Growth ?
- Operating Margin Growth ?
- Earnings Growth ?
- Earnings Momentum ?
- Earnings Surprises ?
- Analyst Earnings Revisions ?
- Cash Flow ?
- Return on Equity ?
Previous Close
$2.10
Market Cap
84.25M
PE Ratio
18.44
EPS
0.1131
Volume (Avg. Vol.)
58,047
Day's Range
$2.06 - $2.12
52-Week Range
$2.00 - $3.45
Dividend & Yield
N/A (N/A)
